Roberto Gambino

Six months of resveratrol supplementation has no measurable effect in type 2 diabetic patients. A randomized, double blind, placebo-controlled trial.

R. Gambino, M. Cassader, G. Pagano, 2016, Pharmacological research.

Incidence of diabetes mellitus, cardiovascular outcomes and mortality after a 12-month lifestyle intervention: A 9-year follow-up.

N. Pellegrini, R. Gambino, M. Cassader, 2018, Diabetes & metabolism.

Is left ventricular hypertrophy a low-level inflammatory state? A population-based cohort study.

R. Gambino, M. Cassader, S. Bo, 2012, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Anti-inflammatory and antioxidant effects of resveratrol in healthy smokers a randomized, double-blind, placebo-controlled, cross-over trial.

R. Gambino, M. Cassader, S. Bo, 2013, Current medicinal chemistry.

Plasma Adiponectin Levels in Primary Biliary Cirrhosis: A Novel Perspective for Link Between Hypercholesterolemia and Protection Against Atherosclerosis

A. Floreani, G. Musso, R. Gambino, 2008, The American Journal of Gastroenterology.